Exponent, Inc. (NASDAQ:EXPO) Q4 2025 Earnings Call Transcript February 5, 2026 Exponent, Inc. beats earnings expectations.

With a ceremony in the lecture hall of the Alte Akademie in Freising, the Leibniz Institute for Food Systems Biology at the ...

A small glass vial buried nearly two millennia ago is forcing archaeologists to confront an uncomfortable truth about ancient ...

Allschwil, Switzerland - February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker ...

Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells. What makes it ...

Newborns predict musical beats but show no response to melodies. The surprising reason rhythm dominates infant brains from ...

Watching proteins move as they drive the chemical reactions that sustain life is one of the grand challenges of modern ...

Q I understand that there is treatment for the beginning stages of Alzheimer’s disease that can stave off serious decline.

From the warm, humid rainforests of Southeast Asia to the harsh, dry conditions of the Tibetan Plateau, over 125 tarantula ...

A new documentary by a local filmmaker is a tribute to Linnea Mills, but it also exposes the shocking details surrounding how she died.

It addresses a widespread problem that makes SPF tough to use.

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...